NIPT available as standard option for all pregnant women from 1 April From 1 April 2023, the Non-Invasive Prenatal Test (NIPT) will be available to all pregnant women. They do not have to take part in a scientific study for this.
Cancer screening programmes now more accessible to transgender and intersex persons Since October 2022, is it has become easier for transgender and intersex persons to take part in cervical cancer screening and breast cancer screening. Transgender and intersex persons with a uterus and/or breast tissue can register with Bevolkingsonderzoek Nederland.
Vaccines very effective against hospital and ICU admissions, also for Delta variant COVID-19 vaccines work well in preventing people from being admitted to hospital or ICU for COVID-19, according to a new analysis by RIVM.
COVID-19 vaccination reduces transmission Vaccination against COVID-19 reduces the transmission of the virus from one person to another. This is apparent from RIVM research using data from source and contact tracing by the Municipal Public Health Services (GGDs).
Nearly 85% of people aged 18 and over have had at least one vaccination The RIVM vaccination update this week has been expanded to include three maps of the Netherlands. For the first time, it is now possible to see vaccination turnout by municipality for everyone aged 18 years and over.